Original Publication Date: 1 October, 2014
Publication / Source: Future Oncology
Authors: Georgios D Lianos, Alberto Mangano, Stefano Rausei, Christos Katsios, Dimitrios H Roukos
Recent evidence on tumor heterogeneity shapes a new era in achieving personalized cancer medicine. Indeed, despite advances in modern oncology with standardized single biopsy-based approaches, limitations still exist in predicting resistance to therapies and tumor progression.